Zier K S, Leo M M, Spielman R S, Baker L
Diabetes. 1984 Jun;33(6):552-5. doi: 10.2337/diab.33.6.552.
Synthesis of interleukin-2 (IL-2) by lymphocytes from 26 insulin-dependent diabetic subjects (IDDM) was compared with that by lymphocytes from 24 nondiabetic control subjects. The control group produced 1.001 +/- 0.071 U/ml (mean +/- SEM). The IDDM group, containing patients diagnosed between 5 days and 10 yr before testing, produced only 0.59 +/- 0.050 U/ml (P less than 0.002). IL-2 synthesis by 6 non-insulin-dependent diabetic subjects (NIDDM) was not decreased (mean +/- SEM, 1.20 +/- 0.04 U/ml). Moreover, decreased levels of IL-2 production was found with lymphocytes of patients in good control, as well as those in poor control. These data suggest that decreased IL-2 synthesis is specific for IDDM, not explainable solely as a consequence of poor metabolic control, and thus, might be involved in the pathogenesis of the disease.
将26名胰岛素依赖型糖尿病患者(IDDM)淋巴细胞产生白细胞介素-2(IL-2)的情况与24名非糖尿病对照者淋巴细胞产生IL-2的情况进行了比较。对照组产生的IL-2为1.001±0.071 U/ml(均值±标准误)。IDDM组(包括在检测前5天至10年被诊断出的患者)产生的IL-2仅为0.59±0.050 U/ml(P<0.002)。6名非胰岛素依赖型糖尿病患者(NIDDM)的IL-2合成未降低(均值±标准误,1.20±0.04 U/ml)。此外,无论是病情控制良好还是控制不佳的患者,其淋巴细胞产生IL-2的水平均降低。这些数据表明,IL-2合成降低是IDDM所特有的,不能单纯解释为代谢控制不佳的结果,因此可能参与了该疾病的发病机制。